Meet Our Medical Advisory Board

The Accordant Medical Advisory Board comprises some of the nation's top medical specialists in the fields of neurology, rheumatology, pulmonology, hematology, and gastroenterology. The Medical Advisors work closely with Accordant to research, develop, test and continuously improve all of our products and services to ensure patients receive the best care for their condition.

Our Medical Advisors are actively involved in the research of diseases and the development of treatments. They use their specialized knowledge to help Accordant design indepth care management tools used by our nurses and available to our members online. Their expert input is used to create clinical decision support systems that allow us to better understand the unique needs of our patients and when to provide appropriate nurse interventions. Medical Advisory Board Members are also an ongoing source of knowledge, training and support for our nurses, and they play an important role in helping us re.ne all our clinical decision support tools.

Pam Becker, MD, PhD

Gaucher Disease


Pam Becker

Dr. Becker is a Professor of Medicine/Hematology at the University of Washington School of Medicine. She earned her medical degree at the Harvard Medical School/Massachusetts Institute of Technology Health Sciences and Technology Program. She earned her PhD in Cell and Developmental ...

Click for Full Bio

Dr. Becker is a Professor of Medicine/Hematology at the University of Washington School of Medicine. She earned her medical degree at the Harvard Medical School/Massachusetts Institute of Technology Health Sciences and Technology Program. She earned her PhD in Cell and Developmental Biology from the Harvard Graduate School's Division of Medical Sciences. She is a current member in numerous professional societies including the American Society of Hematology and the American Society for Gene and Cell Therapy, and was the principal investigator on an NIH grant "Glucocerebrosidase Gene Transfer to the Nervous System," that ran through 2004. She has been an invited speaker at a host of national, international and regional conferences, and is a contributing author on 100 peer-reviewed journal publications, more than 100 abstracts, and 18 book chapters.

Mark Bromberg, MD, PhD

ALS, CIDP, Myasthenia Gravis and Inflammatory Myopathies


Mark Bromberg

Dr. Bromberg received his medical degree from the University of Michigan where he also completed his residency training in neurology and fellowship training in electromyography (EMG) and neuromuscular diseases. Dr. Bromberg received a doctoral degree in neurophysiology ...

Click for Full Bio

Dr. Bromberg received his medical degree from the University of Michigan where he also completed his residency training in neurology and fellowship training in electromyography (EMG) and neuromuscular diseases. Dr. Bromberg received a doctoral degree in neurophysiology from the University of Vermont and completed postdoctoral research training in the field of motor control. He was on the faculty in the Department of Neurology at the University of Michigan for seven years before joining the faculty at the University of Utah in 1994 where he focuses on neuromuscular disorders with special interests in ALS, myasthenia gravis, peripheral neuropathies and dystrophies, in addition to special EMG techniques. Dr. Bromberg is on the editorial board of Journal of Clinical Neurophysiology, Journal of Clinical Neuromuscular Disease and Muscle and Nerve, and is an ad hoc reviewer for Neurology. He has published more than 115 peer-reviewed journal publications and has written 35 chapters in books, and recently edited a book Motor Neuron Disease in Adults.


Andrew Campbell, MD

Sickle Cell Anemia


Andrew Campbell

Dr. Campbell is Associate Professor of Pediatrics at George Washington School of Medicine and Health Sciences and Director of the Comprehensive Sickle Cell Program at Children's National. Dr. Campbell's distinguished training and career path began at Morehouse College. He ...

Click for Full Bio

Dr. Campbell is Associate Professor of Pediatrics at George Washington School of Medicine and Health Sciences and Director of the Comprehensive Sickle Cell Program at Children's National. Dr. Campbell's distinguished training and career path began at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children's Hospital (Northwestern University). Prior to joining Children's National, he was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships, and renal complications.

Kelvin L. Chou, MD

Parkinson's Disease


Kelvin L. Chou

Kelvin L. Chou, M.D., is Professor of Neurology and Neurosurgery at University of Michigan (U-M) Medical School, where he serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program. After receiving his medical degree from the U-M Medical School in 1998 ...

Click for Full Bio

Kelvin L. Chou, M.D., is Professor of Neurology and Neurosurgery at University of Michigan (U-M) Medical School, where he serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program. After receiving his medical degree from the U-M Medical School in 1998, Dr. Chou went on to complete his neurology residency at the Hospital of the University of Pennsylvania in Philadelphia, and a movement disorders fellowship at Pennsylvania Hospital in Philadelphia.

Dr. Chou's research focuses on improving the ability to treat movement disorders patients through DBS by better understanding the relationships between patient baseline characteristics, DBS targeting, and the clinical effects of stimulation. In addition, Dr. Chou is interested in gaining a better understanding of non-motor features of PD and conducts clinical trials on new medical treatments for both PD and Huntington's disease. Board-certified in neurology and psychiatry, Dr. Chou is a Fellow of the American Academy of Neurology, and a member of the Movement Disorders Society, the Parkinson Study Group (PSG) and Huntington Study Group. He also serves on the Education Committee of the Movement Disorders Society and is a member of the Professional Advisory Board of the Michigan Parkinson Foundation. He has published over 75 peer-reviewed journal articles and 10 book chapters on Parkinson's disease, movement disorders, and deep brain stimulation. He has been selected to the Best Doctors in America list each year since 2011.


Patricia K. Coyle, MD, FAAN, FANA

Multiple Sclerosis


Patricia K. Coyle

Dr. Coyle is Professor of Neurology and Vice Chair (Clinical Affairs) in the Department of Neurology at the School of Medicine of the State University of New York at Stony Brook. Dr. Coyle is an elected member of the American Neurological Association where she has held leadership ...

Click for Full Bio

Dr. Coyle is Professor of Neurology and Vice Chair (Clinical Affairs) in the Department of Neurology at the School of Medicine of the State University of New York at Stony Brook. Dr. Coyle is an elected member of the American Neurological Association where she has held leadership positions. She has also served on numerous committees of the National Multiple Sclerosis Society and American Academy of Neurology. Dr. Coyle was a research fellow at Johns Hopkins in Neuroimmunology and Neurovirology. She has presented dozens of papers at national association meetings and has over 400 presentations, presented abstracts and over 200 published articles and reviews. She received her medical degree from Johns Hopkins, completed an internship at Cornell University, and completed her neurology residency and chief residency at Johns Hopkins.

Sushila Dalal, MD

Crohn's Disease and Ulcerative Colitis


Sushila Dalal

Dr. Dalal is Assistant Professor of Medicine at the University of Chicago Medicine and is board certified in Internal Medicine and Gastroenterology. She is a graduate of the University Chicago Pritzker School of Medicine and completed her residency and fellowship in Gastroenterology at ...

Click for Full Bio

Dr. Dalal is Assistant Professor of Medicine at the University of Chicago Medicine and is board certified in Internal Medicine and Gastroenterology. She is a graduate of the University Chicago Pritzker School of Medicine and completed her residency and fellowship in Gastroenterology at the University of Chicago Medicine. She is currently a member of the American Gastroenterology Association and the Crohn's & Colitis Foundation of America. Dr. Dalal is a gastroenterologist with expertise in the treatment of inflammatory bowel diseases and currently is a faculty member at the University of Chicago inflammatory Bowel Disease Center.


Adam Dicker, MD, PhD

Radiation Oncology


Adam Dicker

Adam Dicker, MD, PhD, is Senior Vice President, Professor and Chair of Enterprise Radiation Oncology, Sidney Kimmel Cancer Center, Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia PA...

Click for Full Bio

Adam Dicker, MD, PhD, is Senior Vice President, Professor and Chair of Enterprise Radiation Oncology, Sidney Kimmel Cancer Center, Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia PA.

Dr. Dicker's work has resulted in establishment of parameters for quality assurance in radiation oncology, robotic technologies for brachytherapy, novel therapeutic clinical trials utilizing targeted therapies and ionizing radiation, innovative preclinical models to evaluate radiation modifiers and FDA/CMS approval of a genomic signature for management of prostate cancer

Dr. Dicker leads a University-wide effort in Digital Health, using the convergence of mobile technology, platforms, networks, and machine learning to improve the lives of patients and leads a course in Digital Health in the Medical College. His group created an Apple ResearchKit app for patient reported outcomes (PROs) for prostate cancer patients "Strength Through Insight"-NCT03197948 and are conducting innovative, collaborative research to transform digital health into a standard part of clinical care. Their research is focused on collection of PROs and remote activity monitoring for patients receiving chemo-radiation, molecular targeted therapies and immunotherapy and are expanding to the non-oncology patient population. Dr. Dicker's research supported by the Prostate Cancer Foundation is focused on radiation-immunotherapy approaches integrated with digital health technologies to improve the lives of patients.

Dr. Dicker is Chair Emeritus, Integration Panel for the Prostate Cancer Research Program-Department of Defense, Vice-Chair, Translational Science and Digital Health committees for NRG Oncology (www.nrgoncology.org), and Radiation Oncology Co-Chair, NCI Genitourinary Cancers Prostate Cancer Task Force. He is a member of the National Cancer Institute Investigational Drug Steering Committee, and National Clinical Trial Network Core Correlative Sciences Committee (CTEP).

Dr. Dicker received his BA from Columbia College, and his MD and PhD (Molecular Pharmacology) from Cornell University. He received his training in radiation oncology at Memorial Sloan-Kettering Cancer Center after a surgical internship.

Patrick A. Flume, MD

Cystic Fibrosis (Adult)


Patrick A. Flume

Dr. Flume is a Professor of Medicine and Pediatrics at the Medical University of South Carolina where he directs the Cystic Fibrosis Center and the Adult CF Program. He is The Powers-Huggins Endowed Chair for Cystic Fibrosis. He also serves as Assistant Provost for Research Compliance and ...

Click for Full Bio

Dr. Flume is a Professor of Medicine and Pediatrics at the Medical University of South Carolina where he directs the Cystic Fibrosis Center and the Adult CF Program. He is The Powers-Huggins Endowed Chair for Cystic Fibrosis. He also serves as Assistant Provost for Research Compliance and Regulatory Affairs. He earned his medical degree from the University of Texas Health Science Center at San Antonio where he also completed his residency training. His post-graduate training includes a fellowship in Pulmonary and Critical Care Medicine at the University of North Carolina at Chapel Hill. Dr. Flume is involved in clinical trials regarding the safety and efficacy of new treatments for CF. He has presented his findings at nearly 100 conferences, been a contributing author to 80 peer-reviewed journal publications and written several book chapters. He serves on numerous professional societies and currently sits on three committees for the Cystic Fibrosis Foundation.


Timothy Harbst, MD

Pain Management


Timothy Harbst

Dr. Harbst served as Chairman of Physical Medicine and Rehabilitation at the Gundersen Clinic of LaCrosse Wisconsin for 25 years. His practice is primarily focused on musculoskeletal pain management, with an emphasis on disorders of the spine and extremities. He is board certified in ...

Click for Full Bio

Dr. Harbst served as Chairman of Physical Medicine and Rehabilitation at the Gundersen Clinic of LaCrosse Wisconsin for 25 years. His practice is primarily focused on musculoskeletal pain management, with an emphasis on disorders of the spine and extremities. He is board certified in Pain Medicine, in addition to PM&R. Dr. Harbst lectures frequently on treatment and management of spinal disorders and chronic pain. He serves on the editorial board of The Back Letter (1991-present) and previously The Journal of Back and Musculoskeletal Rehabilitation (1990-1999). He has published several book chapters in the area of spine disorders and pain, as well information for physical therapist about medical emergencies and exercise in traumatic brain injury. He is a graduate of the University of Louisville School of Medicine, and completed his residency training at the University of Wisconsin-Madison. He is actively involved in teaching, developing outcome studies in pain and daily patient care.

Un Jung Kang, MD

Parkinson's Disease


Un Jung Kang

Dr. Un Jung Kang is Professor of Neurology at Columbia University. He is a clinician scientist, specializing in the diagnosis, treatment, research of neurodegenerative disorders that manifest abnormal involuntary movements, such as Parkinson's disease, Huntington's disease, torsion ...

Click for Full Bio

Dr. Un Jung Kang is Professor of Neurology at Columbia University. He is a clinician scientist, specializing in the diagnosis, treatment, research of neurodegenerative disorders that manifest abnormal involuntary movements, such as Parkinson's disease, Huntington's disease, torsion dystonia, tics, and tremor. He is the director of the Division of Movement Disorders and Parkinson Disease Foundation Center at Columbia University. He has co-authored over 120 original research and review articles and book chapters. He serves on the review committees and advisory boards for NIH and various foundations focused on movement disorders. Dr. Kang obtained his B.A. from the University of Chicago and M.D. from the Johns Hopkins University. He trained in neurology and in subspecialty of movement disorders at Columbia University's Neurological Institute of New York. Subsequently, he trained in basic scientific research, first at Cornell University and then at University of California, San Diego, in molecular biology and gene therapy before joining the faculty of the University of Chicago. His main research goal is building translational bridge between basic science discoveries and clinical application. His laboratory investigates mechanisms of motor response complications and of neuronal degeneration in Parkinson's disease, using mouse and cellular models. He is also involved in therapeutic trials of new medications and surgical interventions for Parkinson's disease.


Joshua Klapow, PhD

Behavioral Health


Joshua Klapow

Joshua C. Klapow is a Chief Behavioral Scientist at ChipRewards Inc., a health engagement technology company based in Birmingham, Alabama. He is also a licensed clinical psychologist and Associate Professor of Public Health at the University of Alabama at Birmingham ...

Click for Full Bio

Joshua C. Klapow is a Chief Behavioral Scientist at ChipRewards Inc., a health engagement technology company based in Birmingham, Alabama. He is also a licensed clinical psychologist and Associate Professor of Public Health at the University of Alabama at Birmingham. Dr. Klapow's research focuses on the role of behavioral science in healthcare delivery system design. Dr. Klapow received his Ph.D. in clinical psychology with a specialization in Behavioral Medicine from the University of California San Diego in 1995. He also completed a fellowship in Geropsychiatry at the University of California San Diego in 1996.

Dr. Klapow's work has examined:

  • delivery system design and its impact on the management of chronic illness;
  • the role of provider behavior in disease prevention and management; and
  • the role of psychosocial and behavioral factors in determining health outcomes.

He is the author of more than 100 professional articles, abstracts, and book chapters in the area of behavioral medicine and health psychology. He is also the author of "Living SMART: 5 Essential Skills to Change Your Health Habits Forever," a consumer-focused book on lifestyle change. Dr. Klapow has served as a consultant for chronic conditions and behavioral science for a variety of healthcare organizations including HMOs, third party administrative organizations; prescription benefits management companies, e-health technology companies, quality improvement organizations, and the World Health Organization.

Richard P. Kraig, PhD, MD

Neurology - Headache


Richard P. Kraig

Dr. Richard Kraig is an expert in migraine patient care, migraine research and cerebrovascular disease research. His clinical interests focus on the diagnosis and treatment of migraine headaches. He oversees the Cerebrovascular Disease and Aging Laboratories, which focus on migraine ...

Click for Full Bio

Dr. Richard Kraig is an expert in migraine patient care, migraine research and cerebrovascular disease research. His clinical interests focus on the diagnosis and treatment of migraine headaches. He oversees the Cerebrovascular Disease and Aging Laboratories, which focus on migraine, stroke, epilepsy and cognitive decline from aging.

An active researcher, Dr. Kraig leads investigations to determine how physical, mental and social activities can lessen the impact of neurological disease. Examination of such mechanisms by which the brain naturally protects itself may lead to more selective cellular and molecular targets, as well as new therapeutic strategies against brain disease. Dr. Kraig's research helps him to develop individualized treatment plans for patients in the Migraine Headache Clinic. He is also involved in teaching medical students, graduate students and residents.


Ilo E. Leppik, MD

Epilepsy


Ilo E. Leppik

Dr. Ilo E. Leppik is the Director of the Epilepsy Research and Education Program and Professor of Pharmacy and Neurology at the University of Minnesota. Dr. Leppik is the past President of the American Epilepsy Society, past Chairman of the American Epilepsy Society Guidelines Task Force, and ...

Click for Full Bio

Dr. Ilo E. Leppik is the Director of the Epilepsy Research and Education Program and Professor of Pharmacy and Neurology at the University of Minnesota. Dr. Leppik is the past President of the American Epilepsy Society, past Chairman of the American Epilepsy Society Guidelines Task Force, and the past president of the Central Society for Neurological Research. He also was on the Board of Directors of the Epilepsy Foundation of America and chaired its professional advisory board.

He maintains an active outpatient practice at MINCEP Epilepsy Care and is on the active staffs of University of Minnesota-Fairview Hospital, Masonic Children's Hospital and Abbott Northwestern Hospital. A major current effort is working with nursing home medical directors to improve use of drugs in nursing homes and use of canine epilepsy to translate promising drugs from the laboratory to humans.

Major honors include The Penfield Prize from the Montreal Neurologic Institute and the William G Lennox Award (for lifetime achievement) from the American Epilepsy Society 2007.

From 1986 to 2006 he was a founding and managing editor of an international journal, Epilepsy Research.

Dr. Leppik's research is widely published with over 230 peer reviewed articles and 260 abstracts. He has authored or coauthored a number of books including Contemporary Diagnosis and Management of the Patient With Epilepsy of which more than 650,000 copies have been printed. He authored "Epilepsy: A Guide to Balance Your Life", sponsored by the American Academy of Neurology as part of their educational series for consumers.

Sung Sam Lim, MD, MPH

RA, SLE and Scleroderma


Sung Sam Lim

Dr. Lim is Professor of Medicine and Epidemiology at Emory University School of Medicine. He is the Clinical Director in the Division of Rheumatology and the Chief of Rheumatology for Grady Health Systems. Dr. Lim is site principal investigator for nine ongoing clinical trials studying the safety and efficacy of ...

Click for Full Bio

Dr. Lim is Professor of Medicine and Epidemiology at Emory University School of Medicine. He is the Clinical Director in the Division of Rheumatology and the Chief of Rheumatology for Grady Health Systems. Dr. Lim is site principal investigator for nine ongoing clinical trials studying the safety and efficacy of new treatments for lupus and has several other investigator-initiated research projects funded by the government and private organizations, including a R01 grant from the NIH and U01 from the CDC. His other research interests include epidemiology and outcomes research in lupus and rheumatoid arthritis. Dr. Lim has written book chapters on rheumatoid arthritis and lupus and has authored and co-authored numerous peer-reviewed publications. Dr. Lim is a member of several professional societies, including the American College of Rheumatology and Lupus Foundation of America, where he is the chair of the medical advisory board of the state chapter and on Medical-Scientific Advisory Council of the national LFA. He is a former President of the Georgia Society of Rheumatology. He has been honored by the American College of Rheumatology and by the Lupus Foundation of America for his contributions to research and disease treatment. Dr. Lim received his medical degree from State University of New York at Brooklyn and completed his residency and fellowship training at Emory University School of Medicine.


Aliza R. Lipson, MD

RA, SLE and Scleroderma


Aliza R. Lipson

Dr. Aliza Lipson is Assistant Professor of Medicine in the Division of Rheumatology at Emory University School of Medicine. She is also the Associate Clinical Director of Quality Improvement for the Division of Rheumatology. She has published several papers studying epicardial fat and ...

Click for Full Bio

Dr. Aliza Lipson is Assistant Professor of Medicine in the Division of Rheumatology at Emory University School of Medicine. She is also the Associate Clinical Director of Quality Improvement for the Division of Rheumatology. She has published several papers studying epicardial fat and rheumatic diseases. She serves on the American College of Rheumatology Health Information Technology Committee and leads the Emory Department of Medicine Clinical IT Subcommittee. Dr. Lipson graduated from the University of Miami School of Medicine prior to completing both her Internal Medicine Residency and Rheumatology Fellowship at Emory University in Atlanta, Georgia.

Alice Ma, MD

Hemophilia


Alice Ma

Dr. Ma received her MD at the University of Michigan and did her residency in Internal Medicine and her fellowship in Hematology at the University of Pennsylvania. She has been at the University of North Carolina since 1998, where she is now a Professor of Medicine and Director of the ...

Click for Full Bio

Dr. Ma received her MD at the University of Michigan and did her residency in Internal Medicine and her fellowship in Hematology at the University of Pennsylvania. She has been at the University of North Carolina since 1998, where she is now a Professor of Medicine and Director of the Hematology/Oncology Fellowship Program. She specializes in bleeding disorders, including Hemophilia and Von Willebrand Disease, as well as in disorders of platelets. She directs the first year medical school course on hematology and has received a number of teaching awards. She has served the American Society of Hematology in roles focusing on education, quality, and evaluation.


Aaron Miller, MD

Multiple Sclerosis


Aaron Miller

Dr. Miller is professor of neurology and the medical director at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Icahn School of Medicine at Mt. Sinai in New York. He is the senior medical advisor of the National Multiple Sclerosis Society and served as chairman of the ...

Click for Full Bio

Dr. Miller is professor of neurology and the medical director at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Icahn School of Medicine at Mt. Sinai in New York. He is the senior medical advisor of the National Multiple Sclerosis Society and served as chairman of the Medical Advisory Board from 2002 to 2009. Dr. Miller is a member of the board of directors of the National Multiple Sclerosis Society. His term on the executive committee of the board of directors of the American Academy of Neurology will expire April 2017. He has served as co-chairman of the education committee of the American Academy of Neurology, was the first chairman of the AAN's section on MS, and has been president of the Consortium of MS Centers. He was the former director of the Division of Neurology at Maimonides Medical Center in Brooklyn and co-director of the institution's Multiple Sclerosis Care Center.

Dr. Miller also currently serves as editor of Continuum Audio, which is a joint activity of the American Academy of Neurology and Audio Digest and based on the print version of Continuum, the AAN's bimonthly journal dedicated to lifelong learning in neurology. He previously served 10 years as editor of Continuum. Dr. Miller is a graduate of the New York University School of Medicine, and he trained in neurology at the Albert Einstein College of Medicine. He has authored over 80 peer-reviewed journal publications and is currently the principal investigator on numerous clinical trials involving the treatment of MS. Dr. Miller has also served on the steering committee or the data and safety monitoring boards of several trials.

Ighovwerha Ofotokun, MD, MSc.

Human Immunodeficiency Virus


Ighovwerha Ofotokun

Dr. Ofotokun is a Professor of Medicine at Emory University, Department of Medicine, Division of Infectious Diseases. His career is devoted to the care for women living with HIV infection, conducting translational research in HIV/AIDS, and the training and mentoring of the next generation of clinician scientists...

Click for Full Bio

Dr. Ofotokun is a Professor of Medicine at Emory University, Department of Medicine, Division of Infectious Diseases. His career is devoted to the care for women living with HIV infection, conducting translational research in HIV/AIDS, and the training and mentoring of the next generation of clinician scientists. Specifically, his research focuses on antiretroviral clinical pharmacology and long-term complications of HIV disease management among HIV-infected women. His work is well supported by extramural funding and he is the co-PI of NIH funded Atlanta Women's Interagency HIV Study (WIHS), and the Program Director of the Emory Building Interdisciplinary Research Careers in Women's Health (BIRCWH).


KT Park, MD, MS

Crohn's Disease/Ulcerative Colitis (Pediatric)


KT Park

Dr. KT Park is Associate Professor and Co-Director of Stanford Children's IBD Center and the Medical Director of the Short Stay Infusion Unit at Stanford Children's Health. He is the Co-Chair of the PRO-KIIDS Research Registry at Crohn's and Colitis Foundation and Chair of the Clinical Care and ...

Click for Full Bio

Dr. KT Park is Associate Professor and Co-Director of Stanford Children's IBD Center and the Medical Director of the Short Stay Infusion Unit at Stanford Children's Health. He is the Co-Chair of the PRO-KIIDS Research Registry at Crohn's and Colitis Foundation and Chair of the Clinical Care and Quality Committee at North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Dr. Park's expertise is in pharmacotherapy strategies for Crohn's and colitis patients, including dietary interventions to improve the human gut microbiome. He has formal training in health services/policy research with background in biostatistics, study design, database analysis, and decision science from Stanford University. Dr. Park's NIH-funded research is to discover cost-effective pharmaco-therapy strategies to optimize IBD care pathways. He is involved in numerous multi-center research initiatives, including bench-to-bedside pilot studies and industry-sponsored randomized clinical trials. His research team works with academic and industry collaborators to discover novel ways to deliver an optimized and personalized therapy plans for individual patients and families affected by Crohn's disease and ulcerative colitis.

Nancy S. Reau, MD

Hepatitis C


Nancy S. Reau

Dr. Nancy Reau is Section Chief of Hepatology and Associate Director of Organ Transplantation at Rush University Medical Center. She is the current chair of the American Association for the Study of Liver Diseases' public policy. She has been an invited lecturer at numerous presentations ...

Click for Full Bio

Dr. Nancy Reau is Section Chief of Hepatology and Associate Director of Organ Transplantation at Rush University Medical Center. She is the current chair of the American Association for the Study of Liver Diseases' public policy. She has been an invited lecturer at numerous presentations focused on fatty liver disease, viral hepatitis, cirrhosis, and liver transplantation. Her research interests focus on viral hepatitis, liver transplantation, and complications of chronic liver disease. She is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. Her areas of expertise are Hepatitis B and C, Liver Transplantation and Non-alcoholic Liver Disease, with a specialty in Hepatology.


William Rhead, MD, PhD

Gaucher Disease


William Rhead

William J. Rhead, MD, PhD is a professor of Pediatrics and Pathology at the Medical College of Wisconsin where he cares for children and adults with genetic and metabolic diseases. He earned his medical and doctoral degrees from the University of California, San Diego School of Medicine. He is board certified ...

Click for Full Bio

William J. Rhead, MD, PhD is a professor of Pediatrics and Pathology at the Medical College of Wisconsin where he cares for children and adults with genetic and metabolic diseases. He earned his medical and doctoral degrees from the University of California, San Diego School of Medicine. He is board certified in Pediatrics, Clinical Genetics, and Clinical Biochemical Genetics. Dr. Rhead currently serves as principal investigator on several clinical trials and has authored numerous publications exploring human fatty acid oxidation disease, mitochondrial disease, lysosomal storage diseases and urea cycle disorders and newborn screening for genetic disorders.

Marc Riedl, MD, MS

Hereditary Angioedema


Marc Riedl

Marc A. Riedl, MD, is a board-certified allergist/immunologist who specializes in diagnosing and treating angioedema, immune deficiency diseases, asthma, anaphylaxis, food and medication sensitivity, and other related conditions. Dr. Riedl is the clinical director of ...

Click for Full Bio

Marc A. Riedl, MD, is a board-certified allergist/immunologist who specializes in diagnosing and treating angioedema, immune deficiency diseases, asthma, anaphylaxis, food and medication sensitivity, and other related conditions. Dr. Riedl is the clinical director of UC San Diego Health's U.S. HAEA Angioedema Center, which offers comprehensive evaluations and treatment options for people with all forms of angioedema.

An international thought leader on angioedema, Dr. Riedl is a member of the U.S. Hereditary Angioedema Association's Medical Advisory Board and has been a driving force behind hereditary angioedema research. He is extensively published, and his work has appeared in The New England Journal of Medicine, JAMA, Allergy, and Asthma and Immunology, among others.

As a professor in the Department of Medicine at UC San Diego School of Medicine, Dr. Riedl mentors and instructs medical students, residents and fellows. He serves as the training program director for Allergy and Immunology Fellowship Program. Dr. Riedl is also involved in numerous clinical research trials that study novel therapeutics to prevent and treat hereditary angioedema attacks.

He lectures frequently at both national and international medical conferences. He serves on the editorial board for Clinical Immunology and the Journal of Asthma, and is reviewer for many medical journals.

Dr. Riedl completed a fellowship in clinical immunology and allergy at UCLA School of Medicine and a residency in internal medicine at Barnes-Jewish Hospital of Washington University School of Medicine in St. Louis. He earned his medical degree from University of Chicago Pritzker School of Medicine. Dr. Riedl is board-certified in allergy and immunology and clinical pharmacology.

He is a member of numerous professional organizations, including the American Academy of Allergy, Asthma & Immunology, the American College of Allergy, Asthma & Immunology, and the Clinical Immunology Society. Dr. Riedl has also served on the Special Emphasis Grant Review Committee for National Institutes of Health (NIH)-National Institute of Environmental Health Sciences (NIEHS), and as an appointed consultant for the U.S. Food and Drug Administration's Advisory Committee.


Cara A. Rosenbaum, MD

Hematology-Oncology


Cara A. Rosenbaum

Dr. Cara A. Rosenbaum is an Assistant Professor of Medicine at the University of Chicago, specializing in adult hematology/oncology--particularly in the treatment of multiple myeloma and lymphoma, in the care of complications of multiple myeloma and in the use of new therapies ...

Click for Full Bio

Dr. Cara A. Rosenbaum is an Assistant Professor of Medicine at the University of Chicago, specializing in adult hematology/oncology--particularly in the treatment of multiple myeloma and lymphoma, in the care of complications of multiple myeloma and in the use of new therapies. She also performs bone marrow transplantation. Dr. Rosenbaum works closely with radiation oncologists, surgeons and interventional radiologists supporting an integrated approach to patient care. She serves as principal investigator for a number of multiple myeloma and lymphoma clinical trials. Dr. Rosenbaum also has clinical expertise in non-malignant hematologic disorders, including clotting and bleeding disorders.

Dr. Rosenbaum has served recent tenure as Executive Officer in the Alliance cooperative group, an oncology clinical research organization funded by the National Cancer Institute (NCI). In this role, Dr. Rosenbaum worked closely with researchers at the national level and the NCI to develop cancer clinical trials for new therapies in lymphoma, myeloma, leukemia, and bone marrow transplantation.

Cathy G. Rosenfield, MD

Hemophilia and Sickle Cell Disease


Cathy G. Rosenfield

Dr. Rosenfield is an Associate Professor of Pediatrics at Tufts University School of Medicine in Boston. Dr. Rosenfield received her graduate training at the University of Massachusetts Medical School. Her post-graduate training in Pediatrics was completed at Rhode Island Hospital in Providence ...

Click for Full Bio

Dr. Rosenfield is an Associate Professor of Pediatrics at Tufts University School of Medicine in Boston. Dr. Rosenfield received her graduate training at the University of Massachusetts Medical School. Her post-graduate training in Pediatrics was completed at Rhode Island Hospital in Providence, Rhode Island where she later served as a fellow in the Division of Pediatric Hematology/Oncology, and the Children's Hospital National Medical Center in Washington, DC. Dr. Rosenfield also completed a fellowship with the Transfusion Medicine Service at the Puget Sound Blood Center in Seattle, Washington and holds certification in Pediatric Hematology/Oncology with the American Board of Pediatrics. In addition to her academic appointments, Dr. Rosenfield is an active member of numerous medical societies and foundations, including the National Hemophilia Foundation and the American Society of Hematology.


Donald B. Sanders, MD

ALS, CIDP, Myasthenia Gravis and Inflammatory Myopathies


Donald B. Sanders

Dr. Sanders is Professor of Neurology at Duke University Medical Center, where he founded, and for 25 years directed the Myasthenia Gravis Clinic. His major area of interest is the diagnosis and treatment of neuromuscular diseases. Dr. Sanders is a graduate of Harvard Medical School ...

Click for Full Bio

Dr. Sanders is Professor of Neurology at Duke University Medical Center, where he founded, and for 25 years directed the Myasthenia Gravis Clinic. His major area of interest is the diagnosis and treatment of neuromuscular diseases. Dr. Sanders is a graduate of Harvard Medical School and trained in neurology at the University of Virginia under T.R. Johns, MD, a pioneer in the treatment of myasthenia gravis. Dr. Sanders has authored and co-authored over 160 peer reviewed journal publications and lectures extensively on the topic of neuromuscular diseases. He is a past president of both the Medical Advisory Board of the Myasthenia Gravis Foundation of America (MGFA) and the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). He was named Doctor of the Year by the MGFA in 1992 and received the Chairman's Award from that organization in 2014. He received the AANEM Distinguished Researcher Award in 1999, and its Lifetime Achievement Award in 2012.

Michael S. Schechter, MD, MPH

Cystic Fibrosis


Michael S. Schechter

Dr. Schechter is professor and chief of the Division of Pulmonary Medicine in the Department of Pediatrics and director of the Virginia Commonwealth University Cystic Fibrosis Center. As a pulmonologist, he has a special clinical interest in cystic fibrosis and other causes of childhood bronchiectasis ...

Click for Full Bio

Dr. Schechter is professor and chief of the Division of Pulmonary Medicine in the Department of Pediatrics and director of the Virginia Commonwealth University Cystic Fibrosis Center. As a pulmonologist, he has a special clinical interest in cystic fibrosis and other causes of childhood bronchiectasis. He also has extensive experience in bronchoscopy and in the care of children with asthma, airway obstruction, and respiratory complications of systemic diseases such as sickle cell disease and neuromuscular disorders.

His research has been primarily concerned with environmental and sociodemographic influences as well as the impact of treatment variations on outcomes in CF, and he has worked with the CF Foundation on fostering methods to improve the quality of care and outcomes for children with cystic fibrosis. He is an active member of the CFF Comparative Effectiveness Research/Registry Committee and the CFF Mental Health Taskforce.

Dr. Schechter has previously been on the faculty of Wake Forest University, Brown University, and Emory University. He has served on numerous committees of the Cystic Fibrosis Foundation, American Thoracic Society, and American Academy of Pediatrics, and is past chair of the AAP Section of Pediatric Pulmonology. He has been an invited speaker at a host of national and international conferences, and has an extensive record of published research, reviews, commentaries, edited books and book chapters.


Joseph E. Schumacher, PhD

Behavioral Health


Joseph E. Schumacher

Joseph E. Schumacher is a Professor of Medicine, Clinical Addiction Psychologist, and Behavioral Scientist in the Division of Preventive Medicine (DOPM) at the University of Alabama at Birmingham. He earned his PhD in Clinical Psychology from the University of Alabama ...

Click for Full Bio

Joseph E. Schumacher is a Professor of Medicine, Clinical Addiction Psychologist, and Behavioral Scientist in the Division of Preventive Medicine (DOPM) at the University of Alabama at Birmingham. He earned his PhD in Clinical Psychology from the University of Alabama and has been a licensed Clinical Psychologist in Alabama since 1991. He has extensive experience in researching the evidence-based behavioral treatment of drug addiction and its' associated consequences and has supervised the evidence-based treatment of over 3,000 persons with substance related and other mental disorders. Dr. Schumacher is a member of the American Psychological Association and College on Problems of Drug Dependency, co-founder of Olivia's House, and the director of EARTH. In addition to these roles, Dr. Schumacher also collaborates with several community addiction and mental health service agencies locally and conducts research and training internationally in both Eastern Europe and China..

Samuel Volchenboum, MD, PhD

Oncology


Samuel Volchenboum

Samuel L. Volchenboum, MD, PhD, MS, is an expert in pediatric cancers and blood disorders. He has a special interest in treating children with neuroblastoma, a tumor of the sympathetic nervous system. In addition to caring for patients, Dr. Volchenboum is studying neuroblastoma in the laboratory ...

Click for Full Bio

Samuel L. Volchenboum, MD, PhD, MS, is an expert in pediatric cancers and blood disorders. He has a special interest in treating children with neuroblastoma, a tumor of the sympathetic nervous system. In addition to caring for patients, Dr. Volchenboum is studying neuroblastoma in the laboratory, using sophisticated tools to measure the amounts of proteins found in these tumors. He is also pursuing several research projects in biomedical informatics, a field that harnesses tools from the world of computer science to solve complex problems in biology. Dr. Volchenboum has applied informatics techniques to study the genetics of both pediatric and adult cancers, and serves as director of informatics for the Section of Pediatric Hematology/Oncology at the University of Chicago.


Karen Weihs, MD

Psychiatry


Karen Weihs

Karen Weihs is Professor of Psychiatry and a Comprehensive Member of the Arizona Cancer Center. She is Medical Director of Supportive Care and PsychoOncology Services for the Arizona Cancer Center. Dr. Weihs has developed a model for cancer patients' mental health care ...

Click for Full Bio

Karen Weihs is Professor of Psychiatry and a Comprehensive Member of the Arizona Cancer Center. She is Medical Director of Supportive Care and PsychoOncology Services for the Arizona Cancer Center. Dr. Weihs has developed a model for cancer patients' mental health care including family focused care in a collaborative team of oncologists, nurses, nutritionists, complementary therapists, genetic counselors, social workers and psychiatrists.

Dr. Weihs received her MD from the University of Iowa. She completed a residency in Family Medicine and held a faculty position in Family Medicine at Brown University for four years, where she practiced inpatient, obstetrics and outpatient family practice, along with teaching medical students and residents and conducting research on teaching medical interviewing. Following her work as a family physician, Dr. Weihs did a residency in adult and child psychiatry at the University of Wisconsin, in Madison. Dr. Weihs sees patients referred from the Arizona Cancer Center for clinical psychiatry care and supervises residents in consultation liaison psychiatry and brief, psychodynamic psychotherapy. Her research areas include: depression and medical illness, close relationships and health outcomes and PsychoOncology, with funding from the National Institutes of Health, the American Cancer Society, and the Congressional Mandated Medical Research Program through the Department of Defense.

Dr. Weihs was a member of the CVS/Caremark National Pharmacy and Therapeutics Committee from 1999 - 2004. She has conducted numerous industry sponsored clinical trials of psychopharmacologic agents for treatment of anxiety and depressive disorders in adults and in children.

Anne-Marie Wills MD, MPH

ALS, Parkinson's Disease


Anne-Marie Wills

Anne-Marie Wills M.D. M.P.H. is an Assistant Professor of Neurology at Harvard Medical School specializing in neurodegenerative disease, such as Parkinson's Disease and A.L.S. She received her B.A. from Princeton University, her M.D. from Columbia College Physicians & Surgeons, and ...

Click for Full Bio

Anne-Marie Wills M.D. M.P.H. is an Assistant Professor of Neurology at Harvard Medical School specializing in neurodegenerative disease, such as Parkinson's Disease and A.L.S. She received her B.A. from Princeton University, her M.D. from Columbia College Physicians & Surgeons, and her M.P.H. from Harvard School of Public Health. She completed her specialty training in the Partners Neurology residency program, a combined program between Massachusetts General Hospital and Brigham and Women's Hospital. She has been on staff at M.G.H. since 2006.

Her research focuses on environmental risk factors and determinants of neurodegenerative disease progression, including nutrition, caffeine and pesticides. She is currently the Principal Investigator of a clinical trial funded by the ALS Association to study the effects of nutrition on A.L.S. (Lou Gehrig's Disease) patients, because both human and animal data show a strong increase in survival from excess calories and body weight. She is also the M.G.H. Investigator on several Parkinson's Disease clinical trials testing therapeutic interventions in P.D.


Andrew N. Wilner, MD, FACP, FAAN

Epilepsy


Andrew N. Wilner

Dr. Wilner graduated from Yale University and Brown University School of Medicine. He is board certified in both internal medicine and neurology. He completed a fellowship in electroencephalography at the Montreal Neurological Institute, Montreal, Canada. He was medical director of the ...

Click for Full Bio

Dr. Wilner graduated from Yale University and Brown University School of Medicine. He is board certified in both internal medicine and neurology. He completed a fellowship in electroencephalography at the Montreal Neurological Institute, Montreal, Canada. He was medical director of the Carolinas Epilepsy Center, Charlotte, NC, followed by appointment as Clinical Associate Professor of Neurology at Brown University School of Medicine, Providence, RI. Subsequently, he worked at Hennepin County Medical Center, Minneapolis, MN, the Mayo Clinic, Phoenix, AZ, and other locations as a locum tenens neurologist. Dr. Wilner is currently Associate Professor of Neurology at the University of Tennessee Health Science Center, and staff neurologist at Regional One Medical Center in Memphis, TN.

Dr. Wilner has been a medical advisor for the Accordant Health Services Epilepsy Disease Management Program, Greensboro, NC, for nearly 20 years. Dr. Wilner and Accordant colleagues have published papers in Epilepsy and Behavior detailing the excess cost burden of epilepsy compared to controls and highlighted the problem of comorbidities (Wilner et al. 2012, 2014, 2016).

Dr. Wilner has worked for many years as medical journalist with more than 1,000 publications. He is also a radio host for ReachMD.com.

Dr. Wilner received the American Academy of Neurology's Creative Expression of Human Values Award (2001), the American Academy of Neurology's Journalism Fellowship for Excellence in Medical/Health Reporting (2008), and is the author of two books on epilepsy; Epilepsy: 199 Answers, 3rd Edition, and Epilepsy in Clinical Practice. His latest book, Bullets and Brains, a collection of over 100 essays on neurology, was published in 2013.

Dr. Wilner volunteers as the medical director of Lingkod Timog, a nonprofit medical mission organization that delivers health care to rural areas of the Philippines. For more information, see www.drwilner.org and bulletsandbrains.net.

David Wyles, MD

Human Immunodeficiency Virus


David Wyles

Dr. David Wyles is Chief of the Infectious Diseases Division in the Department of Medicine at Denver Health. Dr. Wyles graduated from the Northwestern University Feinberg School of Medicine in 1998. He completed his Internal Medicine residency and Infectious Diseases fellowship at the University of ...

Click for Full Bio

Dr. David Wyles is Chief of the Infectious Diseases Division in the Department of Medicine at Denver Health. Dr. Wyles graduated from the Northwestern University Feinberg School of Medicine in 1998. He completed his Internal Medicine residency and Infectious Diseases fellowship at the University of Colorado Health Sciences Center. Dr. Wyles was an Associate Professor of Medicine in the Division of Infectious Diseases at the University of California, San Diego before joining the staff at Denver Health.

Dr. Wyles' research interests include the conduct of HCV clinical trials, in vitro evaluation of new antiviral therapies for Hepatitis C virus (HCV), and HCV drug resistance. He is also a member of the AASLD/IDSA HCV guidelines panel and serves on the International Antiviral Society – USA Hepatitis Advisory Board. Clinically Dr. Wyles is involved in care of patients with HCV and HCV/HIV-1 co-infection.


Brian Zanoni, MD

Human Immunodeficiency Virus (Pediatric)


Brian Zanoni

Dr. Zanoni obtained his MD from Georgetown University and completed a combined internal medicine and pediatrics residency at Baylor College of Medicine. He then worked in sub-Saharan Africa from 2006 to 2012 treating both adults and children with HIV and TB, conducting pediatric ...

Click for Full Bio

Dr. Zanoni obtained his MD from Georgetown University and completed a combined internal medicine and pediatrics residency at Baylor College of Medicine. He then worked in sub-Saharan Africa from 2006 to 2012 treating both adults and children with HIV and TB, conducting pediatric HIV-outcomes research, and training local staff in HIV management. While living in South Africa, he founded the Teen Clinic at Don McKenzie Hospital and the non-profit organization, Umndeni Care Program which focuses on in-home HIV and TB testing and linkage to care in rural KwaZulu-Natal. He completed an Infectious Disease and HIV fellowship at Massachusetts General Hospital and Brigham and Woman's Hospital and received an MPH from Harvard T.H. Chan School of Public Health. He is currently an instructor at Harvard Medical School and Massachusetts General Hospital. His research focuses on transition care for HIV-infected adolescents in South Africa.